22 results
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
and financial condition and results of operations;
A pandemic, epidemic, or outbreak of an infectious disease, such as SARS-CoV-2 (severe acute respiratory … of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry.
A pandemic, epidemic
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:45pm
and financial condition and results of operations;
A pandemic, epidemic, or outbreak of an infectious disease, such as SARS-CoV-2 (severe acute respiratory … of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry.
A pandemic, epidemic
10-K
2023 FY
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Annual report
4:48pm
condition and results of operations;
A pandemic, epidemic, or outbreak of an infectious disease, such as SARS-CoV-2 (severe acute respiratory syndrome … of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry.
A pandemic, epidemic, or outbreak
424B4
CHRO
Chromocell Therapeutics Corp.
20 Feb 24
Prospectus supplement with pricing info
5:30pm
agreements or arrangements, disruptions or instability in the financial services industry.
A pandemic, epidemic, or outbreak of an infectious disease … -19 pandemic, we reduced staff and slowed down development activities as capital and testing options available to us were more limited. The extent
424B4
CHRO
Chromocell Therapeutics Corp.
20 Feb 24
Prospectus supplement with pricing info
5:28pm
.
A pandemic, epidemic, or outbreak of an infectious disease, such as COVID-19, may materially and adversely affect our business and our financial results … and laboratory space is located. In response to the COVID-19 pandemic, we reduced staff and slowed down development activities as capital and testing